Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cannabidiol (Epidiolex) (3 trials)
Crohn Disease (Phase 2)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis, Autoimmune (Phase 2)
Urticaria (Phase 2)
Trials (3 total)
Trial APIs (1 total)